Surgical and Non Surgical Treatment Option in Poly Cystic Ovary Cases

Sponsor
Sohag University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05699356
Collaborator
(none)
150
1
5.5
27.2

Study Details

Study Description

Brief Summary

The study will focus on treatment of Poly Cystic Ovary Syndrome patients with infertility The aim is to to find the best treatment by comparison of surgical and non surgical intervention

Condition or Disease Intervention/Treatment Phase
  • Other: Non Surgical treatment
  • Procedure: laparoscopic drilling
  • Behavioral: Treatment of Poly cystic ovary for infertility by Life style modification
  • Procedure: Treatment of Poly cystic ovary for infertility by Assisted reproductive technique

Detailed Description

INTRODUCTION Infertility is the failure of couples to conceive after one year of having regular unprotected coitus 1, 2&3 Globally there are 48 -186 million people cases reported with infertility. The common causes of infertility are being male factor, tubal peritoneal factor, cervical mucus, an ovulatory disorders and others causes including anti-sperm antibodies, luteal phase deficiency, diabetic mellitus, genital tract infection 1,2&4 Infertility is often multifactorial so during treatment multiple investigations should be conducted 2 Anovulation cover 30% of all infertility cases, is a complex process by which there is a failure of ovary to release mature ovarian follicles and involves a lot of potential causes 2&5 The clinical symptoms of anovulating cycles are irregular periods, light or heavy menses, deficiency of cervical mucus, Irregular Basal Body Temperature (BBT) 2&5 The common causes of anovulatory cycle is Polycystic Ovarian Syndrome (PCOS), other causes are due to hypothalamus or pituitary gland dysfunction, Premature ovarian failure, high serum estradiol in follicular phase, age above 45, hyper prolactinemia, subclinical hypothyroidism, drugs, luteinized unruptured follicles, Diabetes mellitus, athletic activity and people who do not eat and become very slim 1,2&5 Polycystic Ovarian Syndrome (PCOS) is a condition in a female of child bearing age characterized by menstrual disorders, hyperandrogenism, multiple ovarian cysts and anovulatory cycle 6 The causes of this condition are idiopathic, but the following reasons are highly suggested to be associated with PCO 6&7 Insulin resistance develop from excess insulin lead the body to produce more androgen and causing anovulatory cycle 6 women with PCOS have low grade inflammation that stimulates Poly cystic ovaries to produce androgen which can lead changes in blood vessels and heart 6 PCOS also may be due familiar susceptibility 6 The sign and symptoms of PCO are Menstrual disorders including missed period more than 35 days, infrequent period less 9 menses in a year, irregular menses light or heavy period 6&7 Hyperandrogenism manifestation like hirsutism, clitoromegaly, masculinization, severe acne, in severe form of PCO (hyperthecosis) there is deepening of voice 6, 7&8 History of infertility due to intermittently ovulation, the condition also is associate with higher chance of miscarriage 8 Polycystic ovaries presence of numerous small cysts filled with fluid in the ovaries 6&7 Majority of PCO patients are obese which worsen the symptoms of PCO 6&8 About 10 % of PCO cases have type 2 Diabetic Mellitus and 30-40 % at age of 40 have impaired glucose tolerance test 8 Sleep apnea which predispose PCO affected patients to cardiovascular disease 8 COMPLICATION OF PCO Infertility, gestational diabetes, Pregnancy induce hypertension, abortion or pre term birth, steatohepatitis, cardiovascular disease, Type 2 diabetes or prediabetes, lack of sleep, depression, thinning of hair, anxiety and eating disorder, abnormal uterine bleeding, acanthosis nigricans, armpit and under breasts, endometrial cancer a1 a2 The treatment of PCO is widely including life style modification, drug treatment, FDA safety alerts, metabolic derangements, anovulation, hirsutism, diet and activity, surgical intervention a3

Study Design

Study Type:
Observational
Anticipated Enrollment :
150 participants
Observational Model:
Case-Only
Time Perspective:
Retrospective
Official Title:
Surgical and Non Surgical Treatment Option in Poly Cystic Ovary Cases, A Meta Analysis Study
Actual Study Start Date :
Oct 11, 2022
Anticipated Primary Completion Date :
Mar 20, 2023
Anticipated Study Completion Date :
Mar 28, 2023

Arms and Interventions

Arm Intervention/Treatment
Surgical treatment of Poly cystic ovary for infertility by laparoscopic drilling

laparoscopic drilling response in Poly Cystic Ovary case

Procedure: laparoscopic drilling
Surgical intervension

Non-surgical treatment of Poly cystic ovary for infertility

induction,Anti estrogen,Insulin sensitizing agent, Aromatase Inhibitor,Gonadotropin

Other: Non Surgical treatment
Non Surgical
Other Names:
  • Induction, Aromatase inhibitor,Insulin sensitizing agent,Gonadotropin,Anti estrogen
  • Treatment of Poly cystic ovary for infertility by Life style modification

    Life style modification response in Poly Cystic Ovary case for treatment of infertility

    Behavioral: Treatment of Poly cystic ovary for infertility by Life style modification
    Non Surgical
    Other Names:
  • Non surgical treatment option
  • Treatment of Poly cystic ovary for infertility by Assisted reproductive technique

    Assisted reproductive technique response in Poly Cystic Ovary case for treatment of infertility

    Procedure: Treatment of Poly cystic ovary for infertility by Assisted reproductive technique
    Surgical intervention
    Other Names:
  • Surgical treatment option
  • Treatment of Poly cystic ovary for infertility by controlling menstrual disorders

    Controlling menstrual disorders response in Poly Cystic Ovary case for treatment of infertility

    Other: Non Surgical treatment
    Non Surgical
    Other Names:
  • Induction, Aromatase inhibitor,Insulin sensitizing agent,Gonadotropin,Anti estrogen
  • Treatment of Poly cystic ovary for infertility by Cutaneous manifestation

    Cutaneous manifestation response in Poly Cystic Ovary case for treatment of infertility

    Other: Non Surgical treatment
    Non Surgical
    Other Names:
  • Induction, Aromatase inhibitor,Insulin sensitizing agent,Gonadotropin,Anti estrogen
  • Outcome Measures

    Primary Outcome Measures

    1. The rate of ovulation after life modification [6 months]

      The study will focus on different methods of health modification like health eating, exercise and weight loss and their ability to keep hormones in normal ranges and cause ovulation

    2. Rate of ovulation by medical treatment like Clomifene Citrate and Letrozole [6 months]

      The study also will focus on different medical treatment method like Clomifene Citrate, lentrozole for induction in ovulation

    3. Rate of regular ovulation after laparoscopic Ovarian drilling (Surgical treatment) [6 months]

      The surgery is done to remove part of ovary through laparoscopy which results ovary to restore normal ovulation

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Infertility cases with Poly Cystic Ovary sundrome
    Exclusion Criteria:
    • Infertility cases not related with Poly cystic ovary

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Suhag University hospital Sohag Egypt

    Sponsors and Collaborators

    • Sohag University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Hawala Saleh Mohammed, Resident, Sohag University
    ClinicalTrials.gov Identifier:
    NCT05699356
    Other Study ID Numbers:
    • Soh-Med-22-10-03
    First Posted:
    Jan 26, 2023
    Last Update Posted:
    Jan 26, 2023
    Last Verified:
    Jan 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 26, 2023